Nano X Imaging Ltd (NASDAQ:NNOX)
1.72 USD
-0.090 4.972%Sponsored Reports
| Previous Close (in USD) | 1.81 |
|---|---|
| Change | -0.090 4.972% |
| 52 W H/L (in USD) | 22.690/4.890 |
| EBITDA (in USD) | -44.049M |
| PE Ratio | -- |
| Volume | 731542 |
| Diluted Eps TTM | -1.09 |
| Total Assets (in USD) | 218.648M |
|---|---|
| Total Liabilities (in USD) | 23.134M |
| Revenue TTM (in USD) | 10.011M |
| Cash (in USD) | 56.423M |
| Market Cap (in USD) | 490.626 M |
| Revenue Per Share TTM | 0.175 |
| Gross Profit TTM (in USD) | -6.88M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Nano X Imaging Ltd
Employees: 164
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Ms. Marina Gofman Feler | Chief Legal Officer | NA |
| 2. | Mr. Ran Poliakine | Founder & Chairman | 1969 |
| 3. | Mr. Erez I. Meltzer | CEO & Director | 1957 |
| 4. | Ran Daniel | Chief Financial Officer | 1968 |
| 5. | Mr. Tal Shank | VP of Corp. Devel. | 1978 |
| 6. | Ms. Tamar Aharon Cohen | Exec. VP & Chief Marketing Officer | 1977 |
| 7. | Mr. Gilad Yron | Chief Bus. Officer | 1973 |
| 8. | Mr. James M. Dara | GM of Source & Services Division and Head of Nanox USA | 1970 |
| 9. | Ms. Lydia Edwards | Pres of Nanox US | NA |
| 10. | Dr. Ilung Kim Ph.D. | Head of Nanox Korea | 1959 |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
+1.950 2.199% | 89.355 | 25.970 | 17.241 | 3.570 | 3.200 | 3.805 | 16.753 |
|
SYK
Stryker Corporation |
+2.640 0.857% | 309.24 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
+0.940 1.169% | 81.3 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+0.160 0.342% | 47.25 | 31.490 | 17.241 | 4.407 | 3.650 | 4.878 | 19.194 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -108.921M | -61.846M | -43.815M | -22.563M | -1.909M |
| Minority Interest | - | - | - | - | - |
| Net Income | -105.243M | -61.798M | -43.499M | -22.555M | -1.909M |
| Selling General Administrative | 41.254M | 34.709M | 22.268M | 18.298M | 1.023M |
| Gross Profit | -6.88M | -1.512M | - | - | - |
| Reconciled Depreciation | 11.512M | 2.292M | 0.208M | 0.053M | 0.035M |
| Ebit | -109.71M | -63.85M | -44.131M | -22.571M | -1.904M |
| Ebitda | -37.194M | -61.558M | -43.923M | -22.518M | -1.869M |
| Depreciation And Amortization | 72.516M | 2.292M | 0.208M | 0.053M | 0.035M |
| Operating Income | -109.71M | -61.558M | -43.923M | -22.571M | -1.904M |
| Other Operating Expenses | 87.786M | 62.862M | 43.923M | 22.571M | 1.904M |
| Interest Expense | 60.215M | 2.004M | 0.108M | 0.008M | 0.005M |
| Tax Provision | -3.678M | -0.048M | - | - | - |
| Interest Income | - | - | - | - | - |
| Net Interest Income | 0.789M | -0.288M | 0.108M | 0.008M | -0.005M |
| Income Tax Expense | -3.678M | -0.048M | -0.316M | -0.008M | 0.005M |
| Total Revenue | 8.578M | 1.304M | 0M | 0M | 0M |
| Total Operating Expenses | 72.328M | 60.046M | 43.923M | 22.571M | 1.904M |
| Cost Of Revenue | 15.458M | 2.816M | - | - | - |
| Total Other Income Expense Net | 0.789M | -0.288M | 0.108M | 0.008M | -0.005M |
| Net Income From Continuing Ops | -105.243M | -61.798M | -43.815M | -22.563M | -1.909M |
| Net Income Applicable To Common Shares | -113.243M | -61.798M | -43.815M | -22.563M | -1.909M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 218.648M | 253.933M | 363.17M | 236.149M | 11.871M |
| Intangible Assets | 80.607M | 91.219M | 160.124M | - | - |
| Other Current Assets | 2.32M | 1.446M | 1.966M | 6.325M | 1.564M |
| Total Liab | 23.134M | 29.253M | 71.022M | 5.403M | 20.649M |
| Total Stockholder Equity | 195.514M | 224.68M | 292.148M | 230.746M | -8.778M |
| Other Current Liab | 7.327M | 12.533M | 48.344M | 3.526M | 17.82M |
| Common Stock | 0.165M | 0.158M | 0.149M | 0.131M | 0.075M |
| Capital Stock | 0.165M | 0.158M | 0.149M | 0.131M | 0.075M |
| Retained Earnings | -320.233M | -251.457M | -146.214M | -84.416M | -40.601M |
| Good Will | 0M | 7.42M | 58.298M | - | - |
| Other Assets | 0M | 34.673M | 1.184M | 6.295M | 1.481M |
| Cash | 56.423M | 38.463M | 66.645M | 213.468M | 8.072M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 15.524M | 17.074M | 52.751M | 4.48M | 20.263M |
| Current Deferred Revenue | 0.543M | 0.182M | 0.247M | - | 1.828M |
| Net Debt | -48.027M | -33.844M | -60.873M | -212.026M | -7.546M |
| Short Term Debt | 4.351M | 0.74M | 1.026M | 0.519M | 0.14M |
| Short Long Term Debt | 3.49M | - | 0.145M | - | - |
| Short Long Term Debt Total | 8.396M | 4.619M | 5.772M | 1.442M | 0.526M |
| Other Stockholder Equity | 515.887M | 477.953M | 438.82M | 315.031M | 31.748M |
| Property Plant Equipment | - | 12.962M | 39.16M | 10.061M | 0.754M |
| Total Current Assets | 88.635M | 82.461M | 94.857M | 219.793M | 9.636M |
| Long Term Investments | 0M | 25.198M | 67.845M | - | - |
| Short Term Investments | 26.006M | 39.161M | 22.066M | - | - |
| Net Receivables | 1.484M | 0.977M | 1.051M | - | - |
| Long Term Debt | - | 3.481M | 3.796M | - | - |
| Inventory | 2.356M | 2.414M | 3.129M | - | - |
| Accounts Payable | 3.303M | 3.619M | 3.134M | 0.435M | 0.475M |
| Accumulated Other Comprehensive Income | -0.305M | -1.974M | -0.607M | -0.344M | -0.136M |
| Non Currrent Assets Other | 2.163M | 2.933M | 1.184M | 0.977M | 1.481M |
| Non Current Assets Total | 130.013M | 171.472M | 268.313M | 16.356M | 2.235M |
| Capital Lease Obligations | 4.906M | 1.138M | 1.831M | 1.442M | 0.526M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | 14.606M | -116.32M | -13.937M | -0.125M | -0.073M |
| Total Cashflows From Investing Activities | 14.606M | -116.32M | -13.937M | -0.125M | -0.073M |
| Total Cash From Financing Activities | 0.804M | 7.379M | 240.991M | 13.861M | 3.684M |
| Net Income | -105.243M | -61.798M | -43.815M | -22.563M | -1.909M |
| Change In Cash | -28.243M | -147.012M | 205.567M | 8.212M | -0.06M |
| Begin Period Cash Flow | 66.772M | 213.784M | 8.217M | 0.005M | 0.065M |
| End Period Cash Flow | 38.529M | 66.772M | 213.784M | 8.217M | 0.005M |
| Total Cash From Operating Activities | -43.385M | -38.071M | -21.487M | -5.524M | -3.671M |
| Depreciation | 11.512M | 2.292M | 0.208M | 0.053M | 0.035M |
| Other Cashflows From Investing Activities | - | -116.32M | -116.32M | -116.32M | -116.32M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | - | 0.864M | - | - | - |
| Sale Purchase Of Stock | - | - | - | - | - |
| Other Cashflows From Financing Activities | 0.804M | 7.379M | 0.63M | -0.177M | -0.073M |
| Capital Expenditures | 7.171M | 23.158M | 13.937M | 0.125M | 0.073M |
| Change In Working Capital | -16.945M | 2.747M | -2.661M | 0.741M | -1.912M |
| Other Non Cash Items | 52.401M | -0.002M | - | - | - |
| Free Cash Flow | -50.556M | -61.229M | -35.424M | -5.649M | -3.744M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | iShares Russell 2000 ETF | 2 years ago | 1110915 |
| 2. | CS (Lux) Digital Health Equity SB USD | 2 years ago | 650000 |
| 3. | Fidelity Small Cap Index | 2 years ago | 490296 |
| 4. | iShares Russell 2000 Value ETF | 2 years ago | 398849 |
| 5. | State St Russell Sm/Mid Cp® Indx NL Cl C | 2 years ago | 296500 |
| 6. | ARK Israel Innovative Technology ETF | 2 years ago | 228490 |
| 7. | State St Russell Sm Cap® Indx SL Cl I | 2 years ago | 184052 |
| 8. | Vanguard Russell 2000 ETF | 2 years ago | 178173 |
| 9. | NT R2000 Index Fund - NL | 2 years ago | 133170 |
| 10. | NT R2000 Value Index Fund - NL | 2 years ago | 118362 |
| 11. | Schwab Small Cap Index | 2 years ago | 107095 |
| 12. | NT R2000 Index Fund - DC - NL - 2 | 2 years ago | 105755 |
| 13. | iShares Micro-Cap ETF | 2 years ago | 101209 |
| 14. | Russell 2000 Index Non-Lendable Fund E | 2 years ago | 93066 |
| 15. | iShares Russell 2000 Small-Cap Idx Instl | 2 years ago | 92029 |
| 16. | TFCM Core Growth | 2 years ago | 90824 |
| 17. | NT R2000 Value Index Fund - L | 2 years ago | 84543 |
| 18. | Northern Trust Russell 2000 Value Index | 2 years ago | 84033 |
| 19. | BlackRock Russell 2500™ Index F | 2 years ago | 73087 |
| 20. | Amplify BlueStar Israel Technology ETF | 2 years ago | 67691 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BlackRock Inc | 2 years ago | 3704257 |
| 2. | State Street Corporation | 2 years ago | 1328792 |
| 3. | Credit Suisse First Boston (CSFB) | 2 years ago | 650000 |
| 4. | Morgan Stanley - Brokerage Accounts | 2 years ago | 607361 |
| 5. | Geode Capital Management, LLC | 2 years ago | 578505 |
| 6. | Anson Funds Management LP | 2 years ago | 493099 |
| 7. | Goldman Sachs Group Inc | 2 years ago | 467120 |
| 8. | ARK Investment Management LLC | 2 years ago | 367553 |
| 9. | Johnson & Johnson | 2 years ago | 317704 |
| 10. | Northern Trust Corp | 2 years ago | 312424 |
| 11. | Vanguard Group Inc | 2 years ago | 248661 |
| 12. | Cadian Capital Management LP | 2 years ago | 220000 |
| 13. | Hovey Youngman Associates Inc | 2 years ago | 202411 |
| 14. | Bank of New York Mellon Corp | 2 years ago | 164149 |
| 15. | Nuveen Asset Management, LLC | 2 years ago | 162319 |
| 16. | Susquehanna International Group, LLP | 2 years ago | 155847 |
| 17. | Taylor Frigon Capital Management LLC | 2 years ago | 122113 |
| 18. | Soviero Asset Management, LP | 2 years ago | 120000 |
| 19. | Bank of America Corp | 2 years ago | 117144 |
| 20. | Charles Schwab Investment Management Inc | 2 years ago | 107095 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).